ThioMatrix Forschungs- und Beratungs GmbH
ThioMatrix has established a robust network of partnerships and collaborations with hospitals, veterinary institutions, CROs, and universities. This comprehensive network supports the full development pipeline—from preclinical research through to clinical trials. Combined with our proprietary technologies and in-house expertise, this integrated approach enables us to accelerate time to market and develop optimal delivery systems tailored to your therapeutic candidates.
Basic Information
- Category: business
- Website: https://www.thiomatrix.com/
Documented Facts
- Phone: +43 512 890046 (No linked source recorded for this statement.)
- Email: info@thiomatrix.com (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about ThioMatrix Forschungs- und Beratungs GmbH.
- Canonical profile: https://brandsource.ai/brands/thiomatrix-forschungs-und-beratungs-gmbh
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/thiomatrix-forschungs-und-beratungs-gmbh/json-ld
- Citation profile API: https://brandsource.ai/api/brands/thiomatrix-forschungs-und-beratungs-gmbh/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
ThioMatrix has established a robust network of partnerships and collaborations with hospitals, veterinary institutions, CROs, and universities. This comprehensive network supports the full development pipeline—from preclinical research through to clinical trials. Combined with our proprietary technologies and in-house expertise, this integrated approach enables us to accelerate time to market and develop optimal delivery systems tailored to your therapeutic candidates.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.